4.6 Article

Histone Deacetylase (HDAC)-1,-2,-4, and-6 in Uveal Melanomas: Associations with Clinicopathological Parameters and Patients' Survival

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Immunotherapy in uveal melanoma: novel strategies and opportunities for personalized treatment

Christos Masaoutis et al.

Summary: Novel immunotherapeutic strategies aim to transform immune excluded tumor microenvironment in metastatic UM to T cell inflamed. Encouraging preliminary results have been seen with approaches such as vaccines, adoptive cell transfer, and other novel molecules. Factors like HLA compatibility and expression level of targeted antigens should be considered for optimizing personalized management.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)

Article Cell Biology

The Prognostic Values of PARP-1 Expression in Uveal Melanoma

Malgorzata Gajdzis et al.

Summary: This study found that high expression of PARP-1 in uveal melanoma is associated with unfavorable clinicopathological parameters and prognosis.

CELLS (2021)

Article Medicine, General & Internal

Clinical Significance of Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Salivary Gland Tumors

Despoina Pouloudi et al.

Summary: This study explored the immunohistochemical expression of HDAC-1, -2, -4, and -6 in SGTs and their potential as prognostic biomarkers. The results indicated that HDAC-2 expression was associated with longer overall survival in patients with malignant SGTs, while HDAC-2 positivity and absence of HDAC-6 expression were related to prolonged survival in patients with high-grade malignant SGTs. Moreover, high HDAC-2 expression was significantly associated with longer overall survival in high-grade malignant SGT patients.

DIAGNOSTICS (2021)

Article Oncology

Definition of Biologically Distinct Groups of Conjunctival Melanomas According to Etiological Factors and Implications for Precision Medicine

Sophie Gardrat et al.

Summary: Conjunctival melanoma (ConjMel) is a potentially deadly ocular melanoma that originates from partially sunlight-exposed mucosa. Through sequencing and studying its mutational landscape, we found different molecular subtypes of ConjMel with oncogenic drivers shared with mucosal and skin melanomas.

CANCERS (2021)

Article Oncology

Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma

Zahra Souri et al.

Summary: In Uveal Melanoma (UM), increased expression of several HDACs is associated with the loss of chromosome 3. This study found a positive correlation between the expression of HDACs 1, 3, and 8 and T-cell infiltrates, while HDACs 2 and 11 were negatively correlated with macrophages. Furthermore, stimulation with interferon-gamma induced an increase in certain HDACs, suggesting a potential link with the loss of chromosome 3/BAP1 and inflammation in UM.

CANCERS (2021)

Review Medicine, General & Internal

Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia

Dimitrios Goutas et al.

Summary: HDACs play important roles in tumorigenesis and tumor progression, showing potential as therapeutic targets in cancer treatment. However, their clinical significance as biomarkers in cancer is not fully elucidated. This study aims to emphasize the clinical significance of HDAC isoform expression in different tumor types and their correlations with clinicopathological parameters and patient outcomes.

DIAGNOSTICS (2021)

Article Oncology

HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer

Xue-ting Hu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Article Ophthalmology

Tumour Expression of Histone Deacetylases in Uveal Melanoma

Louis Levinzon et al.

OCULAR ONCOLOGY AND PATHOLOGY (2019)

Review Oncology

The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence

Marilita M. Moschos et al.

ANTICANCER RESEARCH (2018)

Article Medicine, Research & Experimental

Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells

Jiaqi Liu et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2016)

Article Ophthalmology

Uveal melanoma: Estimating prognosis

Swathi Kaliki et al.

INDIAN JOURNAL OF OPHTHALMOLOGY (2015)

Article Pathology

Histone deacetylase 1 and 2 in mesenchymal tumors

Marina Pacheco et al.

MODERN PATHOLOGY (2012)

Article Ophthalmology

CLINICAL SPECTRUM AND PROGNOSIS OF UVEAL MELANOMA BASED ON AGE AT PRESENTATION IN 8,033 CASES

Carol L. Shields et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)

Article Dentistry, Oral Surgery & Medicine

Histone deacetylase-1 and-2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival

Stamatios Theocharis et al.

JOURNAL OF ORAL PATHOLOGY & MEDICINE (2011)

Article Ophthalmology

Uveal Melanoma: Trends in Incidence, Treatment, and Survival

Arun D. Singh et al.

OPHTHALMOLOGY (2011)

Article Oncology

Histone Deacetylase (HDAC) 1 and 2 Expression and Chemotherapy in Gastric Cancer

Kathrin Mutze et al.

ANNALS OF SURGICAL ONCOLOGY (2010)

Review Oncology

HDAC expression and clinical prognosis in human malignancies

Wilko Weichert

CANCER LETTERS (2009)

Review Oncology

Histone deacetylases: target enzymes for cancer therapy

Denis Mottet et al.

CLINICAL & EXPERIMENTAL METASTASIS (2008)

Review Cell Biology

The diverse functions of histone lysine methylation

C Martin et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)

Review Biochemistry & Molecular Biology

The Sir2 family of protein deacetylases

G Blander et al.

ANNUAL REVIEW OF BIOCHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Cytoplasmic IκBα increases NF-κB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3

P Viatour et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Review Biochemistry & Molecular Biology

Histone deacetylases (HDACs): characterization of the classical HDAC family

AJM De Ruijter et al.

BIOCHEMICAL JOURNAL (2003)